Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-5wvtr Total loading time: 0 Render date: 2024-07-21T13:27:04.881Z Has data issue: false hasContentIssue false

Chapter 9 - Cannabinoids and Inflammation and Autoimmune Disorders

from Section 2 - Potential Therapeutic Uses of Cannabinoids in Clinical Practice

Published online by Cambridge University Press:  12 October 2020

Steven James
Steven James
Affiliation:
University of California, San Diego
Get access

Summary

The immune system is a complex system and an essential function critical for good health and survival. Cannabinoid-based treatments hold great promise for future therapeutic uses although our clinical knowledge remains very limited. In this chapter we will review selected preclinical and clinical information that may provide the clinician some insight about the future development of cannabinoids to treat immune diseases. Patients are constantly aware through the internet of numerous anecdotal reports and promotional claims about cannabinoids as remedies and appropriately ask their doctor about recommendations. In such situations the clinician should be aware that the US Food and Drug Administration (FDA), Canada Health and the European Medicines Agency (EMA) have yet to approve any cannabinoid for use in the treatment of immune-related illness.

Type
Chapter
Information
A Clinician's Guide to Cannabinoid Science , pp. 113 - 124
Publisher: Cambridge University Press
Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abramovici, H., Lamour, S.-A. and Mammen, G. (2018) Information for Healthcare Professionals: Cannabis (marihuana, marijuana) and the cannabinoids. Ottawa: Health Canada.Google Scholar
Alhouayek, M. and Muccioli, G. G. (2014) ‘COX-2-derived endocannabinoid metabolites as novel inflammatory mediators’, Trends in Pharmacological Sciences, 35(6), 284–292. doi:10.1016/j.tips.2014.03.001.CrossRefGoogle ScholarPubMed
Blake, D. R. et al. (2006) ‘Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis’, Rheumatology, 45(1), 50–52. doi:10.1093/rheumatology/kei183.CrossRefGoogle ScholarPubMed
Blumstein, G. W. et al. (2014) ‘Effect of delta-9-tetrahydrocannabinol on mouse resistance to systemic Candida albicans infection’, PLoS ONE, 9(7), e103288. doi:10.1371/journal.pone.0103288.Google Scholar
Bredt, B. M. et al. (2002) ‘Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients’, The Journal of Clinical Pharmacology, 42(S1), 82S–89S. doi:10.1002/j.1552-4604.2002.tb06007.x.CrossRefGoogle ScholarPubMed
Cabral, G. A. et al. (1991) ‘Chronic marijuana smoke alters alveolar macrophage morphology and protein expression’, Pharmacology Biochemistry and Behavior, 40(3), 643–649. doi:10.1016/0091-3057(91)90376-D.Google Scholar
Cabral, G. A. et al. (1995) ‘Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells’, Life Sciences, 56(23–24), 2065–2072. doi:10.1016/0024-3205(95)00190-H.CrossRefGoogle ScholarPubMed
Carlisle, S. J. et al. (2002) ‘Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation’, International Immunopharmacology, 2(1), 69–82. doi:10.1016/S1567-5769(01)00147-3.CrossRefGoogle ScholarPubMed
Chao, C. et al. (2008) ‘Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected men’, Drug and Alcohol Dependence, 94(1–3), 165–171. doi:10.1016/j.drugalcdep.2007.11.010.CrossRefGoogle Scholar
Chiurchiù, V. et al. (2013) ‘Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis’, Annals of Neurology, 73(5), 626–636. doi:10.1002/ana.23875.Google Scholar
Chiurchiù, V., Leuti, A. and Maccarrone, M. (2015) ‘Cannabinoid signaling and neuroinflammatory diseases: a melting pot for the regulation of brain immune responses’, Journal of Neuroimmune Pharmacology, 10(2), 268–280. doi:10.1007/s11481-015-9584-2.Google Scholar
Daul, C. B. and Heath, R. G. (1975) ‘The effect of chronic marihuana usage on the immunological status of rhesus monkeys’, Life Sciences, 17(6), 875–881. doi:10.1016/0024-3205(75)90438-5.CrossRefGoogle Scholar
Eisenstein, T. K. and Meissler, J. J. (2015) ‘Effects of cannabinoids on T-cell function and resistance to infection’, Journal of Neuroimmune Pharmacology, 12(2), 204–216. doi:10.1007/s11481-015-9603-3.CrossRefGoogle Scholar
Friedman, H., Klein, T. and Specter, S. (1991) ‘Immunosuppression by marijuana and components’, in Ader, R, Felten, D. L. and Cohen, H (eds.), Psychoneuroimmunology, 2nd ed. New York: Academic Press. pp. 931–953. doi:10.1016/b978-0-12-043780-1.50041-5.Google Scholar
Graham, E. S. et al. (2010) ‘Detailed characterisation of CB2 receptor protein expression in peripheral blood immune cells from healthy human volunteers using flow cytometry’, International Journal of Immunopathology and Pharmacology, 23(1), 25–34. doi:10.1177/039463201002300103.CrossRefGoogle ScholarPubMed
Haynes, B. F., Soderberg, K. A. and Fauci, A. S. (2017) ‘Introduction to the immune system’, in Fauci, A. S. and Langford, C. A. (eds.), Harrison’s Rheumatology, 4th ed. New York: McGraw-Hill. pp. 2–46.Google Scholar
Jackson, A. R., Nagarkatti, P. and Nagarkatti, M. (2014) ‘Anandamide attenuates Th-17 cell-mediated delayed-type hypersensitivity response by triggering IL-10 production and consequent microRNA induction’, PLoS ONE, 9(4), e93954. doi:10.1371/journal.pone.0093954.Google Scholar
Klein, T. W. et al. (2003) ‘The cannabinoid system and immune modulation’, Journal of Leukocyte Biology, 74(4), 486–496. doi:10.1189/jlb.0303101.CrossRefGoogle ScholarPubMed
Lahat, A., Lang, A. and Shomron, B. H. (2012) ‘Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study’, Digestion, 85(1), 1–8. doi:10.1159/000332079.Google Scholar
Lal, S. et al. (2011) ‘Cannabis use amongst patients with inflammatory bowel disease’, European Journal of Gastroenterology and Hepatology, 23(10), 891–896. doi:10.1097/MEG.0b013e328349bb4c.CrossRefGoogle ScholarPubMed
Malfait, A. M. et al. (2000) ‘The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis’, Proceedings of the National Academy of Sciences of the United States of America, 97(17), 9561–9566. doi:10.1073/pnas.160105897.CrossRefGoogle ScholarPubMed
Marquéz, L. et al. (2009) ‘Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue’, PLoS ONE, 4(9), e6893. doi:10.1371/journal.pone.0006893.Google Scholar
McHugh, D. et al. (2008) ‘Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2’, Molecular Pharmacology, 73(2), 441–450. doi:10.1124/mol.107.041863.CrossRefGoogle ScholarPubMed
McHugh, D. et al. (2012) ‘Δ9-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells’, British Journal of Pharmacology, 165(8), 2414–2424. doi:10.1111/j.1476-5381.2011.01497.x.CrossRefGoogle ScholarPubMed
Molina, P. E. et al. (2015) ‘Behavioral, metabolic, and immune consequences of chronic alcohol or cannabinoids on HIV/AIDS: studies in the non-human primate SIV model’, Journal of Neuroimmune Pharmacology, 10(2), 217–232. doi:10.1007/s11481-015-9599-8.Google Scholar
Molina-Holgado, F. et al. (2002) ‘Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures’, Journal of Neuroscience Research, 67(6), 829–836. doi:10.1002/jnr.10165.Google Scholar
Naftali, T. and Häuser, W. (2014) ‘Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study’, Forschende Komplementärmedizin, 21(2), 133–134. doi:10.1159/000362829.Google Scholar
National Academy of Sciences, Engineering, and Medicine (2017) The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: National Academies Press.Google Scholar
Newton, C. A., Klein, T. W. and Friedman, H. (1994) ‘Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection’, Infection and Immunity, 62(9), 4015–4020. doi:10.1128/iai.62.9.4015-4020.1994.CrossRefGoogle ScholarPubMed
Piomelli, D. et al. (2017) ‘A Guide to the National Academy of Science Report on Cannabis: An Exclusive Discussion with Panel Members’, Cannabis and Cannabinoid Research, 2(1), 155–159. doi:10.1089/can.2017.29009.dpi.Google Scholar
Reiss, C. S. (2010) ‘Cannabinoids and viral infections’, Pharmaceuticals, 3(6), 1873–1886. doi:10.3390/ph3061873.CrossRefGoogle ScholarPubMed
Richardson, D. et al. (2008) ‘Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis’, Arthritis Research and Therapy, 10(2), 1–14. doi:10.1186/ar2401.CrossRefGoogle ScholarPubMed
Rockwell, C. E. et al. (2006) ‘Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor γ independently of cannabinoid receptors 1 and 2’, Molecular Pharmacology, 70(1), 101–111. doi:10.1124/mol.105.019117.Google Scholar
Shay, A. H. et al. (2003) ‘Impairment of antimicrobial activity and nitric oxide production in alveolar macrophages from smokers of marijuana and cocaine’, The Journal of Infectious Diseases, 187(4), 700–704. doi:10.1086/368370.CrossRefGoogle ScholarPubMed
Smith, F. L. et al. (1998) ‘Characterization of Δ9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats’, Pharmacology Biochemistry and Behavior, 60(1), 183–191. doi:10.1016/S0091-3057(97)00583-2.CrossRefGoogle ScholarPubMed
Sompayrac, L. (2012) ‘Lecture 1: An overview’, in How the Immune System Works, 4th ed. Chichester: John Wiley & Sons, Ltd. pp. 1–12.Google Scholar
Specter, S., Lancz, G. and Goodfellow, D. (1991) ‘Suppression of human macrophage function in vitro by δ 9-tetrahydrocannabinol’, Journal of Leukocyte Biology, 50(5), 423–426. doi:10.1002/jlb.50.5.423.Google Scholar
Tanasescu, R. and Constantinescu, C. S. (2010) ‘Cannabinoids and the immune system: an overview’, Immunobiology, 215(8), 588–597. doi:10.1016/j.imbio.2009.12.005.CrossRefGoogle ScholarPubMed
Thucydides (430 BC) History of The Peloponnesian War. Translated by R. Crawley in 1874. Public Domain.Google Scholar
Wang, T. et al. (2008) ‘Adverse effects of medical cannabinoids: a systematic review’, CMAJ, 178(13), 1669–1678. doi:10.1503/cmaj.071178.Google Scholar
Weiss, A. and Friedenberg, F. (2015) ‘Patterns of cannabis use in patients with inflammatory bowel disease: a population based analysis’, Drug and Alcohol Dependence, 156, 84–89. doi:10.1016/j.drugalcdep.2015.08.035.CrossRefGoogle ScholarPubMed
Yeshurun, M. et al. (2015) ‘Cannabidiol for the prevention of graft-versus-host-disease after allogeneic hematopoietic cell transplantation: results of a phase II study’, Biology of Blood and Marrow Transplantation, 21(10), 1770–1775. doi:10.1016/j.bbmt.2015.05.018.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×